Miura, T, Noma, H, Furukawa, TA, Mitsuyasu, H, Tanaka, S, Stockton, S, et al. Comparative efficacy and tolerability of pharmacological treatments in the maintenance treatment of bipolar disorder: a systematic review and network meta-analysis. Lancet Psychiatry
2014; 1: 351–9.
Goodwin, FK, Jamison, KR. Manic-Depressive Illness: Bipolar Disorders and Recurrent Depression: Bipolar Disorders and Recurrent Depression.
Oxford University Press, 2007.
Rothwell, PM. External validity of randomised controlled trials: “to whom do the results of this trial apply?”. Lancet
2005; 365: 82–93.
Licht, R, Gouliaev, G, Vestergaard, P, Frydenberg, M. Generalisability of results from randomised drug trials. A trial on antimanic treatment. Br J Psychiatry
1997; 170: 264–7.
Tohen, M, Greil, W, Calabrese, JR, Sachs, GS, Yatham, LN, Oerlinghausen, BM, et al. Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial. Am J Psychiatry
2005; 162: 1281–90.
Geddes, JR, Goodwin, GM, Rendell, J, Azorin, J-M, Cipriani, A, Ostacher, MJ, et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial. Lancet
2010; 375: 385–95.
Licht, RW, Nielsen, JN, Gram, LF, Vestergaard, P, Bendz, H. Lamotrigine versus lithium as maintenance treatment in bipolar I disorder: an open, randomized effectiveness study mimicking clinical practice. The 6th trial of the Danish University Antidepressant Group (DUAG-6). Bipolar Disord
2010; 12: 483–93.
Whitaker, R, Cosgrove, L. Psychiatry Under the Influence: Institutional Corruption, Social Injury, and Prescriptions for Reform.
Palgrave Macmillan, 2015.
Kessing, LV, Hellmund, G, Geddes, JR, Goodwin, GM, Andersen, PK. Valproate v. lithium in the treatment of bipolar disorder in clinical practice: observational nationwide register-based cohort study. Br J Psychiatry
2011; 199: 57–63.
Kessing, LV, Hellmund, G, Andersen, PK. An observational nationwide register based cohort study on lamotrigine versus lithium in bipolar disorder. J Psychopharmacol
2012; 26: 644–52.
Simhandl, C, König, B, Amann, BL. A prospective 4-year naturalistic follow-up of treatment and outcome of 300 bipolar I and II patients. J Clin Psychiatry
2014; 75: 254–63.
Lichtenstein, P, Halldner, L, Zetterqvist, J, Sjolander, A, Serlachius, E, Fazel, S, et al. Medication for attention deficit-hyperactivity disorder and criminality. N Engl J Med
2012; 367: 2006–14.
Karanti, A, Bobeck, C, Osterman, M, Kardell, M, Tidemalm, D, Runeson, B, et al. Gender differences in the treatment of patients with bipolar disorder: A study of 7354 patients. J Affect Disord
2015; 174: 303–9.
Sellgren, C, Landen, M, Lichtenstein, P, Hultman, CM, Langstrom, N. Validity of bipolar disorder hospital discharge diagnoses: file review and multiple register linkage in Sweden. Acta Psychiatr Scand
2011; 124: 447–53.
World Health Organization. International Statistical Classification of Diseases and Related Health Problems (ICD–8).
World Health Organization. International Statistical Classification of Diseases and Related Health Problems (ICD–9).
World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines.
Fazel, S, Zetterqvist, J, Larsson, H, Långström, N, Lichtenstein, P. Antipsychotics, mood stabilisers, and risk of violent crime. Lancet
2014; 384: 1206–14.
Molero, Y, Lichtenstein, P, Zetterqvist, J, Gumpert, CH, Fazel, S. Selective serotonin reuptake inhibitors and violent crime: a cohort study. PLoS Med
2015; 12: e1001875.
Benjamini, Y, Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol
1995; 57: 289–300.
Leifeld, P. texreg: Conversion of statistical model output in R to LATEX and HTML tables. J Stat Softw
2013; 55: 1–24.
Hayes, JF, Marston, L, Walters, K, Geddes, JR, King, M, Osborn, DPJ. Lithium vs. valproate vs. olanzapine vs. quetiapine as maintenance monotherapy for bipolar disorder: a population-based UK cohort study using electronic health records. World Psychiatry
2016; 15: 53–8.
Vieta, E, Günther, O, Locklear, J, Ekman, M, Miltenburger, C, Chatterton, ML, et al. Effectiveness of psychotropic medications in the maintenance phase of bipolar disorder: a meta-analysis of randomized controlled trials. Int J Neuropsychopharmacol
2011; 14: 1029–49.
Smith, LA, Cornelius, V, Warnock, A, Bell, A, Young, AH. Effectiveness of mood stabilizers and antipsychotics in the maintenance phase of bipolar disorder: a systematic review of randomized controlled trials. Bipolar Disorders
2007; 9: 394–412.
Deshauer, D, Fergusson, D, Duffy, A, Albuquerque, J, Grof, P. Re-evaluation of randomized control trials of lithium monotherapy: a cohort effect. Bipolar Disord
2005; 7: 382–7.
Goodwin, GM, Bowden, CL, Calabrese, JR, Grunze, H, Kasper, S, White, R, et al. A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder. J Clin Psychiatry
2004; 65: 432–41.
Hirschfeld, R, Kasper, S. A review of the evidence for carbamazepine and oxcarbazepine in the treatment of bipolar disorder. Int J Neuropsychopharmacol
2004; 7: 507–22.